LRCX
Lam Research Corp
Lam Research Corp historical holders
total: 13
Third Point Lam Research Corp transactions over time
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2026 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q1
Daniel Loeb has been an institutional investor in Lam Research Corp (LRCX) since 2026 Q1. According to 2026 Q1 report, Daniel Loeb holds 75,000 shares with a market value of roughly $16.02M representing 0.77% of their equity portfolio. The fund/company first acquired LRCX in 2026 Q1, initially purchasing 75,000 shares.
Does Daniel Loeb still hold LRCX?
Yes, Daniel Loeb continues to hold Lam Research Corp (LRCX). According to their 2026 Q1 report, they maintain a position of 75,000 shares valued at approximately $16.02M, representing 0.77% of their equity portfolio.
When did Daniel Loeb first invest in LRCX?
Daniel Loeb first invested in Lam Research Corp (LRCX) in 2026 Q1 at the reported quarter-end price of $213.66 per share, acquiring 75,000 shares in their initial purchase.
What is Daniel Loeb's average cost basis for LRCX?
Based on historical transaction data, Daniel Loeb's estimated cost basis for Lam Research Corp (LRCX) is approximately $213.66 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $213.66
LRCX transactions history by Third Point
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.77%
|
75,000
|
$213.66
|
$16,024,500
|
new
|
+0.77%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.